Incidental lung cancers identified at coronial autopsy: Implications for overdiagnosis of lung cancer by screening

Respiratory Medicine

Volumn 99, Issue 4, 2005, Pages 501-507

  Manser, Renee L ^a,b   Dodd, Malcolm ^c   Byrnes, Graham ^d   Irving, Louis B ^a   Campbell, Donald A ^e  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c VICTORIAN INSTITUTE OF FORENSIC MEDICINE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e MONASH MEDICAL CENTRE   (Australia)

Author keywords

Autopsy; Lung cancer; Lung neoplasms; Mass screening; Overdiagnosis bias

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; AUTOPSY; BRONCHUS CARCINOID; CANCER GROWTH; CANCER INCIDENCE; CANCER INVASION; CANCER SCREENING; CANCER STAGING; CARCINOMA IN SITU; CAUSE OF DEATH; CHILD; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOPSY; CARCINOMA; CARCINOMA IN SITU; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHILD; CHILD, PRESCHOOL; DIAGNOSTIC ERRORS; FEMALE; HUMANS; INCIDENTAL FINDINGS; INFANT; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; VICTORIA;

EID: 14844297320     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2004.08.017     Document Type: Article

References (39)

1. C. Henschke D.I. McCauley D.F. Yankelevitz et al. Early Lung Cancer Action Project: Overall design and findings from baseline screening Lancet 354 1999 99-105
2. S. Sone F. Li Z.G. Yang et al. Results of three-year mass screening programme for lung cancer using low-dose spiral computed tomography scanner Br J Cancer 84 1 2001 25-32
3. S. Swensen J.R. Jett J.A. Sloan et al. Screening for lung cancer with low-dose spiral computed tomography Am J Resp Crit Care Med 165 2002 508-513
4. J. Jett Spiral computed tomography screening for lung cancer is ready for prime time Am J Resp Crit Care Med 163 4 2001 812-813
5. Morrison A. Screening. In: Rothman K, Greenland S, editors. Modern Epidemiology, second ed. Philadelphia: Lippincott-Raven Publishers; 1998. p. 499-518
6. W. Black Overdiagnosis: An underrecognised cause of confusion and harm in cancer screening J Natl Cancer Inst 92 16 2000 1280-1282
7. G.M. Strauss R.E. Gleason D.J. Sugarbaker Screening for lung cancer re-examined. A reinterpretation of the Mayo Lung Project randomised trial on lung cancer screening Chest 103 Suppl 4 1993 337S-341S
8. J. Handy J.W. Asaph L. Skokan et al. What happens to patients undergoing lung cancer surgery: Outcomes and quality of life before and after surgery Chest 122 2002 21-30
9. B. Keagy P.J. Starek G.F. Murray J.W. Battaglini M.E. Lores B.R. Wilcox Major pulmonary resection for suspected but unconfirmed malignancy Ann Thoracic Surg 38 4 1984 314-316
10. M. McFarlane A.R. Feinstein C.K. Wells Clinical features of lung cancers discovered as a postmortem "surprise" Chest 90 1986 520-523
11. M. McFarlane A.R. Feinstein C.K. Wells Necropsy evidence of detection bias in the diagnosis of lung cancer Arch Intern Med 146 1986 1695-1698
12. M. McFarlane A.R. Feinstein C.K. Wells C.K. Chan The epidemiologic necropsy: Unexpected detections, demographic selections, and changing rates of lung cancer JAMA 258 3 1987 331-338
13. C. Chan C.K. Wells M.J. McFarlane A.R. Feinstein More lung cancer but better survival: Implications for secular trends in "necropsy surprise" rates Chest 96 1989 291-296
14. K. Suen L.L. Lau V. Yermakov Cancer and old age: An autopsy study of 3,535 patients over 65 years old Cancer 33 1974 1164-1168
15. V.D. Plueckhahn K.J. Breen S.M. Cordner Law and Ethics in Medicine for Doctors in Victoria 1994 V.D. Plueckhahn Geelong
16. Australian Bureau of Statistics. Cause of Death Certification: A Booklet for the Guidance of Medical Practitioners in Completing Medical Certificates of Cause of Death in Australia. Canberra: Australian Bureau of Statistics; 1997
17. Stata Corporation. Stata version 6.0 for Windows. Texas; 1999
18. Altman D. Comparing groups-categorical data. In: Practical Statistics for Medical Research. London: Chapman & Hall; 1991. p. 229-72 [chapter 10]
19. Altman D. Some common problems in medical research. In: Practical Statistics for Medical Research. London: Chapman & Hall; 1991. p. 396-439 [chapter 14]
20. Australian Bureau of Statistics. Deaths, Australia. Canberra: Australian Bureau of Statistics; 2000 (11 December 2000). Report No. 3302.0
21. Australian Bureau of Statistics. Victorian Year Book 1998. Canberra: Australian Bureau of Statistics; 1998
22. Australian Bureau of Statistics. Victorian Year Book 2002. Canberra: Australian Bureau of Statistics; 2002. Report No. 1301.2
23. Knight B. Medical aspects of death. In: Simpson's Forensic Medicine, 11th ed. London: Arnold; 1997. p. 12-4 [chapter 2]
24. T. Aoki H. Nakata H. Watanabe et al. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumour doubling time AJR 174 2000 763-768
25. L.A. Gloeckler Ries Influence of extent of disease, histology and demographic factors on lung cancer survival in the SEER population-based data Semin Surg Oncol 10 1994 21-30
26. C. Chung R. Zaino J.A. Stryker M. O'Neill Jr W.E. DeMuth Jr Carcinoma of the lung: Evaluation of histological grade and factors influencing prognosis Ann Thoracic Surg 33 6 1982 599-604
27. W. Beadenkopf A.K. Polan R.U. Marks L.M. Tornatore Some demographic characteristics of an autopsied population J Chronic Dis 18 1965 333-351
28. S. Sone F. Li Z.G. Yang T. Honda Y. Maruyama S. Takashima M. Hasegawa S. Kawakami K. Kubo M. Haniuda T. Yamanda Results of three-year mass screening programme for lung cancer using low-dose spiral computed tomography scanner Br J Cancer 84 1 2001 25-32
29. S. Dammas E.F. Patz P.C. Goodman Identification of small lung nodules at autopsy: Implications for lung cancer screening and overdiagnosis bias Lung Cancer 33 2001 11-16
30. S. Swensen Screening for cancer with computed tomography BMJ 326 2003 894-895
31. L. Rigler B.J. O'Loughlin R.C. Tucker The duration of carcinoma of the lung Dis Chest 23 1953 50
32. L. Garland W. Coulson E. Wollin The rate of growth and apparent duration of untreated primary bronchial carcinoma Cancer 16 1963 694-707
33. T. Sobue T. Suzuki M. Matsuda T. Kuroishi S. Ikeda T. Naruke Survival for clinical stage I lung cancer not surgically treated: Comparison between screen-detected and symptom-detected cases Cancer 69 1992 685-692
34. B.J. Flehinger M. Kimmel M.R. Melamed The effect of surgical treatment on survival from early lung cancer. Implications for screening Chest 101 4 1992 1013-1018
35. L. Dominioni A. Imperatori F. Rovera A. Ochetti G. Torrigiotti M. Paolucci Stage I nonsmall cell lung carcinoma: Analysis of survival and implications for screening Cancer 89 Suppl 11 2000 2334-2344
36. M. Janssen-Heijnen R.M. Schipper P.P.A. Razenberg M.A. Crommelin J.-W.W. Coebergh Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: A population-based study Lung Cancer 21 1998 105-113
37. O. Miettinen Screening for lung cancer: Do we need randomised trials? Cancer 89 Suppl 11 2000 2449-2452
38. E. Patz P.C. Goodman G. Bepler Screening for lung cancer N Engl J Med 343 2000 1627-1633
39. W. Black D.A. Haggstrom H.G. Welch All-cause mortality in randomised trials of cancer screening J Natl Cancer Inst 94 3 2002 167-173